Co-administration of Clopidogrel-based DAPT and Antisecretory Agents: Comparison of Incidence of Cardiovascular Events-Reference-Cited by-同舟云学术

Co-administration of Clopidogrel-based DAPT and Antisecretory Agents: Comparison of Incidence of Cardiovascular Events

Published:2024-05-31 Issue:2 Volume:41 Page:142-150
ISSN:1226-640X
Container-title:Journal of Korean Society of Health-System Pharmacists
language:en
Short-container-title:J. Korean Soc. Health-Syst. Pharm.

Author:

Lee Hee Won¹,Yu Ha Bin¹,Ko Jong Hee¹,Kim Jae Song¹,Son Eun Sun¹,Yu Yun Mi²

Affiliation:

1. Department of Pharmacy, Severance Hospital, College of Medicine, Yonsei University 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea

2. Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University 85 Songdogwahak-ro Yeonsu-gu, Incheon, 21983, Republic of Korea

Publisher

The Korean Society of Health-System Pharmacists

Link

https://pdf.medrang.co.kr/JKSHP/2024/041/JKSHP041-02-142.pdf

Reference18 articles.

1. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

2. Correction to: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guidelineon Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

3. The Clinical Outcome of Coadminstration of Clopidgrel and Omeprazole in patients undergoing coronary artery stent insertion

4. Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines

5. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel